DEA and HHS Extend COVID-19 Telemedicine Flexibilities for Controlled Medications

Summary

The Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) are extending the use of telemedicine for prescribing controlled medications until December 31, 2025, as part of their ongoing efforts to combat the COVID-19 pandemic.